SNDX logo

SNDX
Syndax Pharmaceuticals Inc

3,782
Mkt Cap
$1.89B
Volume
1.69M
52W High
$25.59
52W Low
$8.58
PE Ratio
-6.49
SNDX Fundamentals
Price
$21.39
Prev Close
$21.00
Open
$21.07
50D MA
$22.91
Beta
1.12
Avg. Volume
1.54M
EPS (Annual)
-$3.29
P/B
28.93
Rev/Employee
$578,362.42
$1,771.37
Loading...
Loading...
News
all
press releases
Torray Investment Partners LLC Invests $2.06 Million in Syndax Pharmaceuticals, Inc. $SNDX
Torray Investment Partners LLC purchased a new position in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) in the 4th quarter, according to the company in its most recent...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Consensus Rating of "Moderate Buy" from Brokerages
Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the fourteen ratings firms that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has as...
MarketBeat·8d ago
News Placeholder
Syndax Pharmaceuticals (NASDAQ:SNDX) Reaches New 52-Week High - Should You Buy?
Syndax Pharmaceuticals (NASDAQ:SNDX) Sets New 12-Month High - Time to Buy...
MarketBeat·17d ago
News Placeholder
Palumbo Wealth Management LLC Invests $1.08 Million in Syndax Pharmaceuticals, Inc. $SNDX
Palumbo Wealth Management LLC purchased a new position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) during the 4th quarter, according to the company in its most recent disclosure with...
MarketBeat·17d ago
News Placeholder
SG Americas Securities LLC Has $2.72 Million Stock Position in Syndax Pharmaceuticals, Inc. $SNDX
SG Americas Securities LLC raised its holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) by 184.5% during the 4th quarter, according to its most recent disclosure with the...
MarketBeat·21d ago
News Placeholder
Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Expected to Rise, The Goldman Sachs Group Analyst Says
The Goldman Sachs Group increased their target price on shares of Syndax Pharmaceuticals from $28.00 to $34.00 and gave the stock a "buy" rating in a research report on Wednesday...
MarketBeat·24d ago
News Placeholder
Syndax Pharmaceuticals, Inc. $SNDX Shares Sold by Assenagon Asset Management S.A.
Assenagon Asset Management S.A. trimmed its holdings in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) by 97.7% in the fourth quarter, according to the company in its most recent...
MarketBeat·24d ago
News Placeholder
Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target Cut to $43.00 by Analysts at Mizuho
Mizuho decreased their target price on Syndax Pharmaceuticals from $45.00 to $43.00 and set an "outperform" rating on the stock in a research note on Tuesday...
MarketBeat·25d ago
News Placeholder
Hennion & Walsh Asset Management Inc. Grows Stake in Syndax Pharmaceuticals, Inc. $SNDX
Hennion & Walsh Asset Management Inc. grew its stake in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) by 236.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned...
MarketBeat·25d ago
News Placeholder
Jefferies Financial Group Reiterates "Buy" Rating for Syndax Pharmaceuticals (NASDAQ:SNDX)
Jefferies Financial Group reissued a "buy" rating and set a $40.00 price target (down from $48.00) on shares of Syndax Pharmaceuticals in a research note on Monday...
MarketBeat·26d ago
<
1
2
...
>

Latest SNDX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.